1. SwitchRx
A new online Tool to guide physicians when switching a
patient from one antipsychotic to another.
This unique resource features:
Suggested tapering and titration
schedules, clinical tips, detailed
information on drug pharmacoki-
netics, and other warnings
Content developed by a panel of
Canadian psychiatry and
psychopharmacology experts
Optional email notifications when
content is updated, and the
opportunity to contribute feedback
Register for free at www.switchrx.ca
Switching Antipsychotic Medications

2. SwitchRx
Our mission is to provide physicians with the most current and useful information to
guide their clinical practice when switching their patients’ antipsychotic treatment
regimens.
SwitchRx was developed by CANMAT and BCMHAS and is based on Canadian guide-
lines and prevailing clinical practice. Our sponsors were not involved in the develop-
ment of content.
online at switchrx.ca
The following pharmaceutical Industry sponsors have provided restricted educational grants to
CANMAT, to assist with the building and operating costs of this site:
Bristol-Myers Squibb Canada • Janssen, Inc. • Pfizer Canada Inc. • Sunovion Pharmaceuticals Canada Inc.